Cargando…
Validation and Clinical Application of Interferon-Gamma Release Assay for Diagnosis of Latent Tuberculosis Infection in Children
BACKGROUND: India has the highest tuberculosis (TB) burden, accounting for one-fifth of the global incidence and two-third of the cases in Southeast Asia with an estimated 1.9 million new cases every year. Identifying and treating latent TB infection (LTBI) can reduce the risk of development of acti...
Autores principales: | Benachinmardi, Kirtilaxmi K, Sangeetha, S, Rao, Mohan, Prema, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822318/ https://www.ncbi.nlm.nih.gov/pubmed/31681551 http://dx.doi.org/10.4103/ijabmr.IJABMR_86_19 |
Ejemplares similares
-
Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis
por: Doan, Tan N., et al.
Publicado: (2017) -
The Usefulness of the Tuberculosis Skin Test and the Interferon-gamma Release Assay in the Diagnosis of Latent Tuberculosis Infection in South Korea
por: Jang, Ju Young, et al.
Publicado: (2014) -
Risk Stratification of Latent Tuberculosis Defined by Combined Interferon Gamma Release Assays
por: Corbière, Véronique, et al.
Publicado: (2012) -
Serial Interferon-gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in Patients Treated with Immunosuppressive Agents
por: Kim, Kyeong-Hee, et al.
Publicado: (2011) -
Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon gamma release assays
por: Talati, Naasha J, et al.
Publicado: (2011)